OTCQX:MRVFF - Post by User
Comment by
daydream1on Mar 21, 2015 8:54am
![](https://assets.stockhouse.com/kentico-cms/0338-00/images/Sprite.svg#id_Post_Views_Icon)
164 Views
Post# 23546469
RE:RE:RE:RE:AGM Meeting
RE:RE:RE:RE:AGM MeetingThere should be an announcement soon about P 2% Phase 3 Trial in Acute Pain. The Company continues to plan for the commencement of a Phase 3 clinical trial in Germany of Pennsaid 2% for the treatment of acute pain. The trial will support regulatory approval applications for Pennsaid 2% in international jurisdictions. Commencement of the trial, which is subject to German regulatory approval, is expected in Q2 2015 with topline results anticipated in Q4 2015.
Unless they manage to screw that too.